Answer to Question 1
2,4
Rationale 1: Calcium antacids are often used as calcium supplements.
Rationale 2: Diminished renal function is a reason to avoid self-directed antacid use.
Rationale 3: There is no reason for perimenopausal women to avoid antacids.
Rationale 4: Many over-the-counter antacids contain significant amounts of sodium.
Rationale 5: There is no reason for those with coronary artery disease to avoid antacids.
Global Rationale: Diminished renal function is a reason to avoid self-directed antacid use. Many over-the-counter antacids contain significant amounts of sodium. Calcium antacids are often used as calcium supplements. There is no reason for perimenopausal women to avoid antacids. There is no reason for those with coronary artery disease to avoid antacids.
Answer to Question 2
1, 2, 4
Rationale 1:A weakness of the DSHEA is that the manufacturer does not need to prove the safety of the supplement.
Rationale 2:Aweakness of the DSHEA is that the accuracy of the label is not regulated.
Rationale 3: The FDA can remove products from the market if they pose a significant risk, which is a strength of the DSHEA.
Rationale 4:A weakness of the DSHEA is that dietary supplements do not need to be tested prior to marketing.
Rationale 5:The safety of dietary supplements differs for each client. This is neither a strength nor a weakness.
Global Rationale: The FDA can remove products from the market if they pose a significant risk, which is a strength of the DSHEA. Weaknesses of the DSHEA are that the manufacturer does not need to prove the safety of the supplement, the accuracy of the label is not regulated, and dietary supplements do not need to be tested prior to marketing. The safety of dietary supplements differs for each client. This is neither a strength nor a weakness.